Advances in Exosomes in Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 361
Special Issue Editor
Interests: nanodrug delivery system; nanomaterials; nanomedicine development; cancer therapy; pharmaceutical formulation development and manufacturing
* Dr. Kibria contributed to this issue in his personal capacity. The views expressed are his own and do not necessarily represent the views of the Food and Drug Administration or the United States Government.
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a new Special Issue, entitled ‘Advances in Exosomes in Drug Delivery Systems’, in Pharmaceutics. This Special Issue aims to provide its readers with an update on the advancement of exosomes as promising drug delivery systems for therapeutic applications.
Exosomes are membrane-based extracellular vesicles that are naturally produced by the cells. The nano size range of exosomes and their unique properties, such as stability, biocompatibility and low immunogenicity, are key advantages, make them suitable for nanoparticulate drug delivery systems and also enable them to be considered as promising delivery carriers for future clinical use. In this Special Issue, we would like to invite scholars who are currently working on the current state of the art in the application of exosome or exosome-inspired systems for drug delivery to submit high-quality research and review articles.
The topic includes, but is not limited to, the following: the composition, biogenesis, isolation and biological and clinical applications of exosomes, as well as the methods employed to characterise them. The biopharmaceutical features of exosomes include the drug/macromolecule loading method, the bioengineering or modification of exosomes and the potential application of exosomes in different diseases.
Dr. Golam Kibria
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- exosomes
- extracellular vesicles
- biogenesis of exosomes
- isolation and characterisation
- engineering of exosomes
- drug delivery
- stability/bioavaiability
- therapeutic application
